Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

New Delhi: US researchers have used modern technology CRISPR interference to identify a new set of genes that contribute to ...

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Researchers have long wondered why some people with high-risk Parkinson’s gene variants develop the disease while others ...

Traditional CRISPR-Cas9 enzymes can have off-target effects, cleaving or otherwise modifying DNA at unintended sites in the genome. The newly published study aims to improve this by using machine ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

A new set of genes that contribute to Parkinson’s disease risk has been identified.